๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inferential product quality control of a multistage batch plant

โœ Scribed by Jay H. Lee; Andrew W. Dorsey; Stephen Russell


Publisher
American Institute of Chemical Engineers
Year
2004
Tongue
English
Weight
263 KB
Volume
50
Category
Article
ISSN
0001-1541

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

A modeling framework is developed that addresses the connectivity of a particular, but commonplace, batch plant configuration. Traditional inferential model building techniques such as partial least squares (PLS) and subspace identification are modified to allow for the identification of models that capture the correlation structure across the plant, so that when a disturbance or deviation is detected in one reactor, such information can be shared with other reactors to improve overall control performance. The ability to use information from other running reactors, as well as from previous batch runs, translates into more informed control decisions leading to better overall plant performance. The developed modeling strategy will be applied using data generated from simulating a rigorous model of the Nylon 6,6 process. ยฉ 2004 American Institute of Chemical Engineers AIChE J, 50: 136โ€“148, 2004


๐Ÿ“œ SIMILAR VOLUMES


Temperature Control of a Bench-Scale Bat
โœ N.โ€‰M. Ghasem; S.โ€‰A. Sata; M.โ€‰A. Hussain ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 481 KB ๐Ÿ‘ 1 views

## Abstract Batch polymerization reactors commonly use optimal temperature control as the strategic operation parameter. This strategy allows for better operability and a more economic process. The main objective of the batch polymerization reactor control is to obtain acceptable product quality. D

Development of retroviral-based gene the
โœ Nancy Sajjadi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 1 views

Gene therapy holds much promise for the treatment of many human diseases. Research focused on improving vector delivery systems, identifying therapeutic genes and designing effective treatment regimens, continues. Meanwhile, many first generation gene therapy products are being evaluated in early ph